Search Results - "EXPRESS Study Investigators"

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial.

Authors: Reich K Nestle FO Papp K et al.

Source: Lancet. 10/15/2005, Vol. 366 Issue 9494, p1367-1374. 8p.